-
,for, Item ID-
- #1292113
- Beckman Coulter #D06227
Immunoassay Reagent / Calibrator Kit Access® B-Type Natriuretic Peptide (BNP) II CLIA Non-Waived For DxI 9000 Access Immunoassay Analyzers 2 X 100 Determinations
REAGENT, ACCESS BNP II DET 2X100
No Image
Features
- The Access BNP II test is intended for use with the Beckman Coulter Access Family of Immunoassay Systems for the In Vitro quantitative measurement of B-type natriuretic peptide (BNP) in plasma specimens using EDTA as the anticoagulant
- The test is intended to be used for an aid in the diagnosis of heart failure (HF) in patients presenting to the emergency department (ED) with clinical suspicion of new onset, acutely decompensated, or exacerbated heart failure; for the risk stratification of patients with acute coronary syndromes; for the risk stratification of patients with heart failure
- More …
Product Details Email
Product Specifications
| McKesson # | 1292113 |
|---|---|
| Manufacturer # | D06227 |
| Brand | Access® |
| Manufacturer | Beckman Coulter |
| Country of Origin | United States |
| Application | Immunoassay Reagent / Calibrator Kit |
| Buy American Act (BAA) Compliant | No |
| CLIA Classification | CLIA Non-Waived |
| CLIA Classified | CLIA Non-Waived |
| Container Type | Pack |
| For Use With | For DXI 9000 Access Immunoassay Analyzers |
| Number of Tests | 2 X 100 Determinations |
| Sample Type | Plasma Sample |
| Specialty | Immunoassay |
| Storage Requirements | Requires Refrigeration |
| Test Category | Heart Health |
| Test Method | Two-step, Sandwich |
| Test Name | B-Type Natriuretic Peptide (BNP) II |
| Trade Agreement Act (TAA) Compliant | No |
| UNSPSC Code | 41116004 |
| Volume | R1a: 3.31 mL, R1b: 3.10 mL, R1c: 3.10 mL |
Features
- The Access BNP II test is intended for use with the Beckman Coulter Access Family of Immunoassay Systems for the In Vitro quantitative measurement of B-type natriuretic peptide (BNP) in plasma specimens using EDTA as the anticoagulant
- The test is intended to be used for an aid in the diagnosis of heart failure (HF) in patients presenting to the emergency department (ED) with clinical suspicion of new onset, acutely decompensated, or exacerbated heart failure; for the risk stratification of patients with acute coronary syndromes; for the risk stratification of patients with heart failure
Frequently Viewed Together
-
,for, Item ID-
- #575746
- Quidel #98000XR
-
,for, Item ID-
- #1280294
- BD #256092
-
,for, Item ID-
- #854001
- Qualigen #25000040
-
,for, Item ID-
- #1193638
- BD #256095
-
,for, Item ID-
- #1003906
- Polymedco #PF1061-KUS
-
,for, Item ID-
- #1171093
- Abbott #08P1021
-
,for, Item ID-
- #1255796
- Abbott #07P8852
-
,for, Item ID-
- #1269383
- Abbott #04S7902
-
,for, Item ID-
- #1269760
- Abbott #04S7921
-
,for, Item ID-
- #1120031
- Abbott #09P3820
-
,for, Item ID-
- #1120038
- Abbott #09P3521
-
,for, Item ID-
- #1128232
- Siemens #10997840
-
,for, Item ID-
- #805810
- Quidel #97000BD